Medical Innovation Exchange

Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis

https://www.fiercebiotech.com/biotech/akero-hits-endpoints-midphase-nash-trial-linking-candidate-improvements-fibrosis

Leave a Comment

Your email address will not be published.

Leave the field below empty!